Next Article in Journal
Application of the Combined QCM-D/LSPR Aptasensor for Penicillin G Detection
Previous Article in Journal
The Scattering Effect-Based Smartphone-Assisted Colorimetric Sensing for Alkaline Phosphatase Detection
Previous Article in Special Issue
Recent Advances in Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Proteins System-Based Biosensors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

CRISPR-Enhanced Colorimetric Aptasensor for Adenosine Triphosphate Detection Based on MoS2-Based Nanozymes

1
School of Biomedical Sciences, Suzhou Chien-Shiung Institute of Technology, Suzhou 215411, China
2
State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China
*
Author to whom correspondence should be addressed.
Biosensors 2025, 15(10), 651; https://doi.org/10.3390/bios15100651
Submission received: 21 August 2025 / Revised: 18 September 2025 / Accepted: 28 September 2025 / Published: 1 October 2025
(This article belongs to the Special Issue CRISPR/Cas System-Based Biosensors)

Abstract

As the direct energy source in organisms, accurate and simple detection of adenosine triphosphate (ATP) is of great significance. Herein, a colorimetric aptasensor for ATP determination was designed by integrating the CRISPR/Cas12a system with an aptamer, and with Prussian blue nanocube and gold nanoparticle co-functionalized MoS2 (MoS2-PBNCs-AuNPs) nanozymes. As expected, the introduced CRISPR/Cas12a system and aptamer could efficiently amplify the detection signal and improve the specific recognition ability, respectively. Meanwhile, the catalytic activity of the MoS2-PBNCs-AuNPs nanozymes can be regulated with the concentration of ATP. The high-affinity binding of ATP to the aptamer competitively inhibited aptamer-crRNA hybridization, causing fewer Cas12 proteins to be activated. As a result, the uncleaved single-stranded DNA (ssDNA) adsorbed onto the surface of nanozymes to effectively enhance their catalytic oxidation capability toward 3,3′,5,5′-tetramethylbenzidine (TMB). According to this phenomenon, this CRISPR-enhanced colorimetric aptasensor can detect down to 0.14 μM ATP with high selectivity, reproducibility, and stability. In addition, acceptable recoveries and low relative standard deviations of the aptasensor for ATP determination suggest that it is promising for application in early detection of clinical-related diseases.

1. Introduction

Adenosine triphosphate (ATP), as the primary energy currency in living organisms, powers essential cellular processes including DNA synthesis, glycolysis, transmembrane transport, and neural signaling [1,2,3]. Abnormal ATP metabolism is often associated with the occurrence of diseases, such as Parkinson’s syndrome, inflammation, hypoglycemia, and Alzheimer’s disease [4,5,6,7,8]. Therefore, quantifying the ATP level in biological fluids plays a vital role in biochemical study and clinical diagnosis. Currently, sensors have been coupled with analytical methods such as high-performance liquid chromatography (HPLC) [9], mass spectrometry [10,11,12], fluorescence assays [13,14,15], electrochemistry [16,17,18], and colorimetry to determine ATP. Among these, colorimetric sensors have been considered as a promising method for ATP detection due to their simplicity, low cost, and not needing expensive equipment. There has been a rapid development of nanozymes; the introduction of nanozymes has greatly improved the sensitivity, stability, and reproducibility of colorimetric sensors, which enlarges their practical application in ATP detection.
Since clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems were introduced to construct biosensors for virus detection, they have attracted significant interest in the field of sensors/biosensors [19,20,21]. In general, the activated Cas proteins can indiscriminately cleave surrounding DNA/RNA signal probes, resulting in a change in the detection signal. Coupling with the colorimetry method, the CRISPR/Cas system has been widely used to detect metal ions [22,23], small biomolecules [24,25], RNA/DNA [26,27,28], proteins [29,30], viruses [31,32], and bacteria [33,34], with exciting performance. For example, Zhao et al. developed a multicolor sensing platform for breast cancer 1 gene (BRCA1) detection by coupling with the CRISPR/Cas12a system and LSPR property of gold nanobipyramids (AuNBPs). Utilizing the etching effect of horseradish peroxidase (HRP) towards AuNBPs, the designed sensor can detect down to 30 pM BRCA1 within 60 min with high selectivity [35]. Yang and co-workers reported a dual-mode biosensor to analyze the complementary DNA of the spike protein gene (S-cDNA) by coupling with the advantages of the CRISPR/Cas12a system and upconversion nanozymes [36]. As expected, the designed biosensor can detect 320 fM and 28.4 pM ATP in luminescence mode and colorimetric mode, respectively, with the help of the CRISPR/Cas system.
Nanozymes, especially Prussian blue-based nanozymes, have been widely used in the development of colorimetric biosensors for detecting target molecules due to their outstanding catalytic properties and excellent chemical stability [37,38,39]. Inspired by the above exciting works, a CRISPR-enhanced colorimetric aptasensor was developed for the detection of ATP by coupling, with the advantages of aptames and MoS2-based nanozymes. As shown in Scheme 1, a Prussian blue nanocube and gold nanoparticle co-functionalized molybdenum disulfide (MoS2-PBNCs-AuNPs) nanozyme with high peroxidase-like activity was synthesized; and it was employed to catalyze 3,3′,5,5′-tetramethylbenzidine (TMB) in the presence of hydrogen peroxide (H2O2). Correspondingly, an obvious colorimetric signal was generated. Importantly, the catalytic performance of MoS2-PBNCs-AuNPs nanozymes was enhanced with the adsorption of single-stranded DNA (ssDNA). In the absence of ATP, ATP aptamer (ATP-Apt) hybridized with crRNA to activate the cleave activity of the Cas12a protein. As a result, the adsorbed ssDNA was cleaved to small fragments by Cas12a, leading to the desorption of ssDNA from the nanozyme surface. Correspondingly, a light-blue solution color and low absorption peak were observed due to the decrease in the catalytic activity of the nanozymes. In the presence of ATP, ATP competitively binds to ATP-Apt due to the high affinity, causing less Cas12a to be activated. Obviously, a blue solution and high absorption peak, located at 652 nm, were obtained. According to this concept, the CRISPR-enhanced colorimetric aptasensor can qualitatively and quantitatively detect ATP with high performance. Moreover, the designed aptasensor can efficiently analyze ATP in real samples.

2. Materials and Methods

2.1. Materials and Reagents

Molybdenum(IV) sulfide (MoS2, <2 mm, 99%), n-butyllithium, chloroauric acid trihydrate (HAuCl4·3H2O, ≥99%), 3,3′,5,5′-tetramethylbenzidine (TMB), adenosine 5′-triphosphate (ATP), adenosine 5′-diphosphate (ADP), adenosine 5′-monophosphate (AMP), guanosine 5′-triphosphate (GTP), and cytidine 5′-triphosphate (CTP) were purchased from Sigma-Aldrich (Shanghai, China). Poly(N-vinyl-2-pyrrolidone) (PVP, MW = 58,000), potassium chloride (KCl), potassium ferricyanide (K3[Fe(CN)6], ≥99.5%), iron(III) chloride (FeCl3), magnesium chloride (MgCl2), sodium acetate (NaAc), glacial acetic acid (HAc), and 30% hydrogen peroxide (H2O2) were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Cas12a protein was supplied by Nanjing Vazyme Biotech Co., Ltd. (Nanjing, China). Tris-HCl buffer (1 M, pH 7.5) and DEPC-treated water were purchased from Sangon Biotech (Shanghai, China). ATP-Apt, crRNA, and ssDNA were also synthesized by Sangon Biotech (Shanghai, China); these were recorded as ACCTGGGGGAGTATTGCGGAGGAAGGT, UAAUUUCUACUAAGUGUAGAUCCUCCGCAAUACUCCCCCAGGU, and TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT, respectively. All aqueous solutions were prepared with twice-deionized water.

2.2. Apparatus

A zeta potential analyzer (Brookhaven Instruments, New York, NY, USA) was used to characterized the different nanomaterials. The UV–vis absorption spectrum was recorded on a Shimadzu UV-3600 spectrophotometer (Tokyo, Japan).

2.3. Preparation of MoS2-Based Nanoenzymes

MoS2-based nanozymes were synthesized according to our previous works [38,39]. Briefly, 0.025 mg mL−1 exfoliated MoS2 solution was mixed with PVP, 40 mM K3[Fe(CN)6], and 2 M KCl at pH 1.5. Subsequently, 40 mM FeCl3 was added to the above mixed solution and reacted for 30 min at 60 °C to obtain MoS2-PBNCs nanozymes under microwave-assisted conditions. Then, 10 mM HAuCl4 was added dropwise to the purified MoS2-PBNCs solution under stirring conditions for 30 min. Finally, MoS2-PBNCs-AuNPs nanozymes were purified by centrifugation and stored at 4 °C in a refrigerator. Transmission electron microscope (TEM) characterization of the MoS2 nanosheet, MoS2-PBNCs, and MoS2-PBNCs-AuNPs was performed on a Hitachi H-7500 instrument (Tokyo, Japan).

2.4. Preparation of the CRISPR-Enhanced Colorimetric Biosensor

At first, a mixture solution containing 100 nM Cas12a, 100 nM crRNA, 100 nM ATP-Apt, and 500 nM ss DNA was prepared at 37 °C for 30 min. In the absence of ATP, MoS2-PBNCs-AuNPs nanozymes were added to the mixture solution and left to react for 15 min. After the reaction, 5 μL of 0.5 mM TMB, 10 μL of 10 mM H2O2, and 25 μL of acetate buffer (pH 4.0) were mixed with the above solution and incubated for 6 min at room temperature. Finally, the solution color and absorption peak intensity at 562 nm were recorded to evaluate the analytical performance. In the presence of ATP, the same process was performed to obtain the solution color and absorption peak intensity.

3. Results and Discussion

3.1. Characterization of MoS2-PBNCs-AuNPs Nanozymes

The morphologies of the different nanomaterials are shown in Figure 1. Obviously, the intercalated MoS2 nanosheet showed a typical layered nanostructure; it was used to prepare different nanozymes. With the assistance of microwaves, about 50 nm of PBNCs was successfully supported on the surface of the MoS2 nanosheet to form MoS2-PBNCs nanocomposites [38]. With the addition of HAuCl4, AuNPs and PBNCs were co-functionalized on the surface of the MoS2 nanosheet, forming the expected MoS2-PBNCs-AuNPs nanozymes.

3.2. ssDNA-Enhanced Catalytic Activity of MoS2-PBNCs-AuNPs Nanozymes

The enhancing effect of ssDNA on the catalytic activity of the MoS2-PBNCs-AuNPs nanozymes was studied. As shown in Figure 2A, the zeta potential of MoS2-PBNCs-AuNPs (column b) shifted from −22.50 mV to −31.29 mV with the addition of ssDNA (column c), confirming the successful adsorption of ssDNA onto the nanozyme. It is noted that TMB carries a positive charge (+8.03 mV, column a) in acetate buffer (pH 4.0), which can adsorb onto the surface of MoS2-PBNCs-AuNPs nanozymes (column d) and ssDNA-functionalized MoS2-PBNCs-AuNPs nanozymes (column e) via electrostatic interaction. Obviously, ssDNA/MoS2-PBNCs-AuNPs nanozymes have more negative charges, meaning they can adsorb the more positively charged TMB substrate to generate higher catalytic performance. To better understand the effect of surface charge on the catalytic activity of MoS2-PBNCs-AuNPs nanozymes, we compared ssDNA with other polymers, including polystyrene sulfonate (PSS), polyacrylic acid (PAA), polyvinylpyrrolidone (PVP), and polyetherimide (PEI). Figure 2B shows that MoS2-PBNCs-AuNPs nanozymes functionalized with negatively charged molecules (ssDNA, PSS, PAA) exhibited enhanced catalytic performance. Meanwhile, MoS2-PBNCs-AuNPs nanozymes decorated with positively charged PEI showed a decrease in catalytic performance. Interestingly, the catalytic activity of uncharged PVP functionalized MoS2-PBNCs-AuNPs nanozymes was almost the same as MoS2-PBNCs-AuNPs nanozymes. It should be noted that ssDNA-functionalized MoS2-PBNCs-AuNPs nanozymes showed the best catalytic activity toward TMB oxidation in this work.

3.3. Detection Feasibility of CRISPR-Enhanced Colorimetric Aptasensor

To evaluate the signal amplification effect of the CRISPR/Cas system, a common colorimetric aptasensor was designed based on MoS2-PBNCs-AuNPs nanozymes. As shown in Figure 3A, the addition of ATP resulted in only a minor change in the absorption peak intensity of the colorimetric aptasensor, which was ascribed to the conformational change in ATP-Apt. The ATP-Apt complex formed may be also adsorbed on the surface of nanozymes, leading to a minor increase in absorption peak intensity. As expected, there was an obvious change in the absorption peak intensity of the CRISPR-enhanced colorimetric aptasensor with the addition of ATP (Figure 3B). The reason is that the activated Cas12a protein efficiently cleaved the ssDNA, leading to fragmented ssDNA being unable to adsorb onto the surface of the nanozymes. Consequently, the absorption peak intensity change (∆A = AATP − Ano ATP) of the CRISPR-enhanced colorimetric aptasensor is about 10.5 times higher than that of the conventional colorimetric aptasensor for 5 μM ATP detection (Figure 3C). All the experimental results suggested that the CRISPR-enhanced colorimetric aptasensor is a promising sensing platform for ATP detection.

3.4. Optimization of Experimental Conditions

To obtain the best sensing performance, the effects of different experimental conditions on the CRISPR-enhanced colorimetric aptasensor were investigated. At first, the molar ratio of the Cas12a protein and crRNA was studied. It can be found that ∆A of the colorimetric aptasensor increased with an increasing ratio of the Cas12a protein and crRNA. The largest ∆A was obtained when the ratio of the Cas12a protein and crRNA reached 1:1 (Figure 4A). Therefore, the same molar concentrations of Cas12a and crRNA was selected as the optimal condition. Similarly, the maximum ∆A was obtained when the reaction temperature was 37 °C (Figure 4B). If the reaction temperature was up to 45 °C, the ∆A of the aptasensor decreased. This is ascribed to the high temperature affecting the catalytic activity of the Cas12a protein. Therefore, the optimal reaction temperature was chosen as 37 °C. Finally, the incubation time of the CRISPR/Cas system was optimized. As shown in Figure 4C, the ∆A of the aptasensor increased with increasing the incubation time over the range of 0–15 min. There was almost no change in ∆A when the reaction time was prolonged to 25 min. To save on the detection time, the optimal incubation time of CRISPR/Cas system was selected as 15 min.

3.5. Analytical Performance of the CRISPR-Enhanced Colorimetric Aptasensor

The performance of the CRISPR-enhanced colorimetric aptasensor for ATP detection was investigated under the optimal conditions. Obviously, a higher ATP concentration resulted in a larger increase in the absorption peak intensity of the CRISPR-enhanced colorimetric aptasensor (Figure 5A). The corresponding solution color also proved this result (inset in Figure 5A). The added ATP competitively bound to ATP-Apt, resulting in a reduction in ATP-Apt bound to crRNA. Correspondingly, fewer Cas12a proteins were activated and less ssDNA was cleaved. Consequently, more ssDNA adsorbed onto the surface of nanozymes, enhancing their catalytic activity. As shown in Figure 5B, a linear range between the ∆A of the CRISPR-enhanced aptasensor and 0.5–5 μM ATP was obtained. The linear equation was obtained as ∆A = 0.119CATP + 0.0674, with a correlation coefficient of 0.992. According to the slope of the equation and standard deviation of the blank samples, the detection limit (LOD) was calculated to be 0.14 μM (S/N = 3), which was comparable to or better than in other published works (Table 1).
To study the selectivity of the CRISPR-enhanced colorimetric apatsensor, adenosine diphosphate (ADP), adenosine monophosphate (AMP), cytidine triphosphate (CTP), and guanosine triphosphate (GTP) were selected as interfering substances. As shown in Figure 5C, the same concentrations of ADP, AMP, CTP, and GTP do not cause an obvious change in the absorption peak intensity. The ∆A of the CRISPR-enhanced colorimetric aptasensor for ATP detection was about 9 times, 6 times, 16 times, and 35 times higher than that for ADP, AMP, CTP, and GTP detection, respectively, indicating that the aptasensor has excellent selectivity (Figure 5D).

3.6. Reproducibility, Stability, and Practical Applicability of This CRISPR-Enhanced Aptasensor

At first, five independent CRISPR-enhanced colorimetric aptasensors were developed to study their reproducibility. The relative standard deviation (RSD) of the five aptasensors for the same concentration of ATP detection was only 2.2%, proving that the designed aptasensor has excellent reproducibility (Figure 6A). After 8 days of storage, the ΔA of the aptasensor was still 81.3% of the initial value (Figure 6B), suggesting that the aptasensor has good storage stability. Subsequently, the standard addition method was used to evaluate the practical application of this CRISPR-enhanced colorimetric aptasensor. As shown in Figure 6C, the recoveries and RSD of the aptasensor for detecting clinically relevant ATP concentrations (1 μM, 2 μM, and 3 μM) in serum were about 95.06–99.50% and 3.53–6.16%, respectively, indicating that the designed colorimetric aptasensor is promising for practical application. In addition, the ΔA of the aptasensor for the same concentrations of ATP detection in 1% serum samples and in ideal PB buffer are almost the same, further suggesting that the developed aptasensor has good anti-interference ability and potential for application in clinical samples (Figure 6D).

4. Conclusions

In summary, a colorimetric aptasensor was successfully developed to sensitively and selectively detect ATP by coupling with the advantages of the CRISPR/Cas system, an aptamer, and MoS2-PBNCs-AuNPs nanozymes. The added ATP can efficiently regulate the number of activated Cas12a proteins, thereby regulating the enhancement effect of ssDNA on MoS2-PBNCs-AuNPs nanozyme activity. Due to the signal being amplified by the CRISPR/Cas system, the designed colorimetric aptasensor exhibited a wide linear range (0.5–5 μM), a low detection limit (0.14 μM), high selectivity, and excellent reproducibility for ATP detection. With its validated detection performance, this aptasensor showed promising applicability for early-stage screening of disease biomarkers.

Author Contributions

Conceptualization, Z.Z. and H.M.; methodology, Z.Z., H.Y. and X.M.; validation, Z.Z. and H.M.; formal analysis, Y.Y. and X.M.; investigation, Z.Z., H.M. and Y.Y.; data curation, H.Y. and Y.Y.; writing—original draft preparation, Z.Z. and H.M.; writing—review and editing, Z.Z. and S.S.; supervision, S.S.; project administration, S.S.; funding acquisition, Z.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Qing Lan Project of Jiangsu Province, the Science and Technology Program of Suzhou (SYW2025037), the Visiting Scholar Project for Higher Vocational Colleges in Jiangsu Province (2024GRFX045), the Science and Technology Program of Taicang (TC2024JCYL23) and the Innovation Team Funds of Suzhou Chien-shiung Institute of Technology (2023JXKYTD01).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Dennis, P.B.; Jaeschke, A.; Saitoh, M.; Fowler, B.; Kozma, S.C.; Thomas, G. Mammalian TOR: A Homeostatic ATP Sensor. Science 2001, 294, 1102–1105. [Google Scholar] [CrossRef]
  2. Knowles, J.R. Enzyme-Catalyzed Phosphoryl Transfer Reactions. Annu. Rev. Biochem. 1980, 49, 877–919. [Google Scholar] [CrossRef]
  3. Khlyntseva, S.V.; Bazel’, Y.R.; Vishnikin, A.B.; Andruch, V. Methods for the determination of adenosine triphosphate and other adenine nucleotides. J. Anal. Chem. 2009, 64, 657–673. [Google Scholar] [CrossRef]
  4. Dröge, W. Free Radicals in the Physiological Control of Cell Function. Physiol. Rev. 2002, 82, 47–95. [Google Scholar] [CrossRef]
  5. Nakano, M.; Imamura, H.; Sasaoka, N.; Yamamoto, M.; Uemura, N.; Shudo, T.; Fuchigami, T.; Takahashi, R.; Kakizuka, A. ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson’s Disease. EBioMedicine 2017, 22, 225–241. [Google Scholar] [CrossRef] [PubMed]
  6. Cai, R.; Zhang, Y.; Simmering, J.E.; Schultz, J.L.; Li, Y.; Fernandez-Carasa, I.; Consiglio, A.; Raya, A.; Polgreen, P.M.; Narayanan, N.S.; et al. Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases. J. Clin. Investig. 2019, 129, 4539–4549. [Google Scholar] [CrossRef] [PubMed]
  7. Beck, S.J.; Guo, L.; Phensy, A.; Tian, J.; Wang, L.; Tandon, N.; Gauba, E.; Lu, L.; Pascual, J.M.; Kroener, S.; et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease. Nat. Commun. 2016, 7, 11483. [Google Scholar] [CrossRef] [PubMed]
  8. Butterfield, D.A.; Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019, 20, 148–160. [Google Scholar] [CrossRef]
  9. Law, A.S.; Hafen, P.S.; Brault, J.J. Liquid chromatography method for simultaneous quantification of ATP and its degradation products compatible with both UV–Vis and mass spectrometry. J. Chromatogr. B 2022, 1206, 123351. [Google Scholar] [CrossRef]
  10. Huang, Y.-F.; Chang, H.-T. Analysis of Adenosine Triphosphate and Glutathione through Gold Nanoparticles Assisted Laser Desorption/Ionization Mass Spectrometry. Anal. Chem. 2007, 79, 4852–4859. [Google Scholar] [CrossRef]
  11. Ocsoy, I.; Gulbakan, B.; Shukoor, M.I.; Xiong, X.; Chen, T.; Powell, D.H.; Tan, W. Aptamer-Conjugated Multifunctional Nanoflowers as a Platform for Targeting, Capture, and Detection in Laser Desorption Ionization Mass Spectrometry. ACS Nano 2012, 7, 417–427. [Google Scholar] [CrossRef]
  12. Li, X.; Liao, X.; Liu, Y.-M. A microfluidic platform integrating paper adsorption-based sample clean-up and voltage-assisted liquid desorption electrospray ionization mass spectrometry for biological sample analysis. Talanta 2020, 217, 121106. [Google Scholar] [CrossRef]
  13. Lang, W.; Wu, Z.-W.; Li, J.; Chen, Y.; Cao, Q.-Y. A novel coumarin-linked tetraphenylethene fluorescent probe for simultaneous sensing of ATP and GSH. Sens. Actuators B Chem. 2024, 412, 135772. [Google Scholar] [CrossRef]
  14. Xu, Z.; Liu, B.; Li, D.; Yu, Z.; Gan, N. Dual-Mode Biosensor for Simultaneous and Rapid Detection of Live and Whole Salmonella typhimurium Based on Bioluminescence and Fluorescence Detection. Biosensors 2023, 13, 401. [Google Scholar] [CrossRef]
  15. Tan, K.-Y.; Li, C.-Y.; Li, Y.-F.; Fei, J.; Yang, B.; Fu, Y.-J.; Li, F. Real-Time Monitoring ATP in Mitochondrion of Living Cells: A Specific Fluorescent Probe for ATP by Dual Recognition Sites. Anal. Chem. 2017, 89, 1749–1756. [Google Scholar] [CrossRef]
  16. Jiang, H.; Liu, X.; Zhao, D.; Jia, Y.-K.; Wang, Y.-Q.; Li, W.; Liu, Z.-P.; Wang, J.-D. An Entropy-Driven Multipedal DNA Walker Microsensor for In Situ Electrochemical Detection of ATP. Anal. Chem. 2024, 96, 20656–20664. [Google Scholar] [CrossRef]
  17. Wang, X.; Yu, T.; Kang, J.; Li, L.; Zhang, D.; Xu, B. Engineered XDNA-YPEP hydrogel with enhanced antifouling capability for ultrasensitive electrochemical assay of adenosine triphosphate in human serum. Sens. Actuators B Chem. 2024, 418, 136256. [Google Scholar] [CrossRef]
  18. Wang, P.; Cheng, Z.; Chen, Q.; Qu, L.; Miao, X.; Feng, Q. Construction of a paper-based electrochemical biosensing platform for rapid and accurate detection of adenosine triphosphate (ATP). Sens. Actuators B Chem. 2018, 256, 931–937. [Google Scholar] [CrossRef]
  19. Nishimasu, H.; Shi, X.; Ishiguro, S.; Gao, L.; Hirano, S.; Okazaki, S.; Noda, T.; Abudayyeh, O.O.; Gootenberg, J.S.; Mori, H.; et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 2018, 361, 1259–1262. [Google Scholar] [CrossRef] [PubMed]
  20. Zhu, C.; Zhang, F.; Li, H.; Chen, Z.; Yan, M.; Li, L.; Qu, F. CRISPR/Cas systems accelerating the development of aptasensors. TrAC Trends Anal. Chem. 2022, 158, 116775. [Google Scholar] [CrossRef]
  21. Xin, X.; Su, J.; Cui, H.; Wang, L.; Song, S. Recent Advances in Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Proteins System-Based Biosensors. Biosensors 2025, 15, 155. [Google Scholar] [CrossRef]
  22. Yu, Y.; Zhang, Y.; Zhao, Y.; Lv, K.; Ai, L.; Wu, Z.; Song, Z.; Zhang, J. Probiotic bacterial adsorption coupled with CRISPR/Cas12a system for mercury (II) ions detection. Biosens. Bioelectron. 2024, 263, 116627. [Google Scholar] [CrossRef]
  23. Qu, Z.; Li, M.; Fu, H.; Li, X.; Li, R.; Liu, B.; Zou, L. DNAzyme-mediated CRISPR/Cas12a bioassay for label-free fluorescence detection of copper(II) ions and dipicolinic acid. Microchem. J. 2025, 210, 112924. [Google Scholar] [CrossRef]
  24. Gong, S.; Song, K.; Zhang, S.; Zhou, P.; Pan, W.; Li, N.; Tang, B. CRISPR-Cas12a-mediated dual-enzyme cascade amplification for sensitive colorimetric detection of HPV-16 target and ATP. Talanta 2023, 266, 125050. [Google Scholar] [CrossRef]
  25. Hu, H.; Guo, S.; Li, Y.; Dong, K.; Lu, Y.; Ye, K.; Li, L.; Zhou, X.; Cheng, L.; Xiao, X. Spatially blocked split CRISPR-Cas12a system for ultra-sensitive and versatile small molecule activation and detection. Nat. Commun. 2025, 16, 5035. [Google Scholar] [CrossRef]
  26. Song, Y.; Shi, J.; Wu, Y.; Huang, K.-J.; Tan, X. Tailoring high-energy self-powered sensing system by Walker-mediated CRISPR/Cas12a cascade signal amplification and hybridization chain reaction for ultrasensitive microRNA detection. Sens. Actuators B Chem. 2023, 399, 134821. [Google Scholar] [CrossRef]
  27. Wang, B.; Xu, Y.-T.; Zhang, T.-Y.; Wang, H.-Y.; Zhang, X.; Wu, Z.-Q.; Zhao, W.-W.; Chen, H.-Y.; Xu, J.-J. An Ultrasensitive and Efficient microRNA Nanosensor Empowered by the CRISPR/Cas Confined in a Nanopore. Nano Lett. 2023, 24, 202–208. [Google Scholar] [CrossRef] [PubMed]
  28. Su, J.; Ke, Y.; Maboyi, N.; Zhi, X.; Yan, S.; Li, F.; Zhao, B.; Jia, X.; Song, S.; Ding, X. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis. Small Methods 2021, 5, 2100935. [Google Scholar] [CrossRef]
  29. Chen, Q.; Tian, T.; Xiong, E.; Wang, P.; Zhou, X. CRISPR/Cas13a Signal Amplification Linked Immunosorbent Assay for Femtomolar Protein Detection. Anal. Chem. 2019, 92, 573–577. [Google Scholar] [CrossRef] [PubMed]
  30. Qi, L.; Liu, J.; Liu, S.; Liu, Y.; Xiao, Y.; Zhang, Z.; Zhou, W.; Jiang, Y.; Fang, X. Ultrasensitive Point-of-Care Detection of Protein Markers Using an Aptamer-CRISPR/Cas12a-Regulated Liquid Crystal Sensor (ALICS). Anal. Chem. 2024, 96, 866–875. [Google Scholar] [CrossRef]
  31. Ding, X.; Yin, K.; Li, Z.; Lalla, R.V.; Ballesteros, E.; Sfeir, M.M.; Liu, C. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat. Commun. 2020, 11, 1–10. [Google Scholar] [CrossRef]
  32. Rahimi, S.; Balusamy, S.R.; Perumalsamy, H.; Ståhlberg, A.; Mijakovic, I. CRISPR-Cas target recognition for sensing viral and cancer biomarkers. Nucleic Acids Res. 2024, 52, 10040–10067. [Google Scholar] [CrossRef]
  33. Kasputis, T.; He, Y.; Ci, Q.; Chen, J. On-Site Fluorescent Detection of Sepsis-Inducing Bacteria using a Graphene-Oxide CRISPR-Cas12a (GO-CRISPR) System. Anal. Chem. 2024, 96, 2676–2683. [Google Scholar] [CrossRef] [PubMed]
  34. Shang, Y.; Xing, G.; Lin, J.; Li, Y.; Lin, Y.; Chen, S.; Lin, J.-M. Multiplex bacteria detection using one-pot CRISPR/Cas13a-based droplet microfluidics. Biosens. Bioelectron. 2023, 243, 115771. [Google Scholar] [CrossRef]
  35. Zhao, Z.; Xiong, Q.; Zhu, Y.; Zhang, C.; Li, Z.; Chen, Z.; Zhang, Y.; Deng, X.; Tao, Y.; Xu, S. CRISPR/Cas12a-Enabled Amplification-Free Colorimetric Visual Sensing Strategy for Point-of-Care Diagnostics of Biomarkers. Anal. Chem. 2024, 97, 1019–1027. [Google Scholar] [CrossRef] [PubMed]
  36. Yan, J.; Yin, B.; Zhang, Q.; Li, C.; Chen, J.; Huang, Y.; Hao, J.; Yi, C.; Zhang, Y.; Wong, S.H.D.; et al. A CRISPR-Cas12a-mediated dual-mode luminescence and colorimetric nucleic acid biosensing platform based on upconversion nanozyme. Biosens. Bioelectron. 2024, 270, 116963. [Google Scholar] [CrossRef]
  37. Kim, J.U.; Kim, J.M.; Thamilselvan, A.; Nam, K.-H.; Kim, M.I. Colorimetric and Electrochemical Dual-Mode Detection of Thioredoxin 1 Based on the Efficient Peroxidase-Mimicking and Electrocatalytic Property of Prussian Blue Nanoparticles. Biosensors 2024, 14, 185. [Google Scholar] [CrossRef]
  38. Su, S.; Han, X.; Lu, Z.; Liu, W.; Zhu, D.; Chao, J.; Fan, C.; Wang, L.; Song, S.; Weng, L.; et al. Facile Synthesis of a MoS2–Prussian Blue Nanocube Nanohybrid-Based Electrochemical Sensing Platform for Hydrogen Peroxide and Carcinoembryonic Antigen Detection. ACS Appl. Mater. Interfaces 2017, 9, 12773–12781. [Google Scholar] [CrossRef]
  39. Zhu, Z.; Gong, L.; Miao, X.; Chen, C.; Su, S. Prussian Blue Nanoparticle Supported MoS2 Nanocomposites as a Peroxidase-Like Nanozyme for Colorimetric Sensing of Dopamine. Biosensors 2022, 12, 260. [Google Scholar] [CrossRef]
  40. Huang, N.; Wen, J.; Yi, D.; Wei, Z.; Long, Y.; Zheng, H. Colorimetric detection of ATP by inhibiting the Peroxidase-like activity of carbon dots. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2022, 268, 120658. [Google Scholar] [CrossRef]
  41. Shimizu, M.; Aikawa, S.; Fukushima, Y. Colorimetric Detection of ATP by a Chlorophosphonazo III -based Mg2+ Complex in Aqueous Solution via Indicator Displacement Approach. J. Fluoresc. 2022, 33, 255–260. [Google Scholar] [CrossRef] [PubMed]
  42. Xu, X.; Nan, D.; Yang, H.; Pan, S.; Liu, H.; Hu, X. Quercetin@ZIF-90 as a novel antioxidant for label-free colorimetric ATP sensing at neutral pH. Sens. Actuators B Chem. 2020, 304, 127324. [Google Scholar] [CrossRef]
  43. Yin, S.-J.; Chen, G.-Y.; Zhang, C.-Y.; Wang, J.-L.; Yang, F.-Q. Zeolitic imidazolate frameworks as light-responsive oxidase-like mimics for the determination of adenosine triphosphate and discrimination of phenolic pollutants. Microchim. Acta 2022, 190, 25. [Google Scholar] [CrossRef]
Scheme 1. Schematic illustration of the CRISPR-enhanced colorimetric aptasensor for ATP detection based on MoS2-based nanozymes.
Scheme 1. Schematic illustration of the CRISPR-enhanced colorimetric aptasensor for ATP detection based on MoS2-based nanozymes.
Biosensors 15 00651 sch001
Figure 1. TEM images of (A) MoS2, (B) MoS2-PBNCs and (C) MoS2-PBNCs-AuNPs.
Figure 1. TEM images of (A) MoS2, (B) MoS2-PBNCs and (C) MoS2-PBNCs-AuNPs.
Biosensors 15 00651 g001
Figure 2. (A) Zeta potentials of (a) TMB, (b) MoS2-PBNCs-AuNPs, (c) ssDNA/MoS2-PBNCs-AuNPs, (d) MoS2-PBNCs-AuNPs + TMB, and (e) ssDNA/MoS2-PBNCs-AuNPs + TMB in 0.2 M acetate buffer (pH 4.0). (B) Peroxidase-like activities of MoS2-PBNCs-AuNPs nanozymes functionalized with different molecules.
Figure 2. (A) Zeta potentials of (a) TMB, (b) MoS2-PBNCs-AuNPs, (c) ssDNA/MoS2-PBNCs-AuNPs, (d) MoS2-PBNCs-AuNPs + TMB, and (e) ssDNA/MoS2-PBNCs-AuNPs + TMB in 0.2 M acetate buffer (pH 4.0). (B) Peroxidase-like activities of MoS2-PBNCs-AuNPs nanozymes functionalized with different molecules.
Biosensors 15 00651 g002
Figure 3. (A) UV–vis absorption spectra and photo (inset) of a conventional colorimetric aptasensor for ATP detection based on MoS2-PBNCs-AuNPs nanozymes. (B) UV–vis absorption spectra and photo (inset) of a CRISPR-enhanced colorimetric aptasensor for ATP detection based on MoS2-PBNCs-AuNPs nanozymes. (C) The performance change of colorimetric aptasensors for ATP detection with CRISPR-enhancement and without CRISPR-enhancement.
Figure 3. (A) UV–vis absorption spectra and photo (inset) of a conventional colorimetric aptasensor for ATP detection based on MoS2-PBNCs-AuNPs nanozymes. (B) UV–vis absorption spectra and photo (inset) of a CRISPR-enhanced colorimetric aptasensor for ATP detection based on MoS2-PBNCs-AuNPs nanozymes. (C) The performance change of colorimetric aptasensors for ATP detection with CRISPR-enhancement and without CRISPR-enhancement.
Biosensors 15 00651 g003
Figure 4. The effects of (A) the Cas12a and crRNA molar ratio, (B) CRISPR/Cas system reaction temperature, and (C) CRISPR/Cas system reaction time on the sensing performance of the CRISPR-enhanced colorimetric aptasensor for ATP detection.
Figure 4. The effects of (A) the Cas12a and crRNA molar ratio, (B) CRISPR/Cas system reaction temperature, and (C) CRISPR/Cas system reaction time on the sensing performance of the CRISPR-enhanced colorimetric aptasensor for ATP detection.
Biosensors 15 00651 g004
Figure 5. (A) UV–vis absorption spectra and photos of the CRISPR-enhanced colorimetric aptasensor in the presence of ATP at increasing concentrations (0.5, 1, 2, 3, 4, and 5 μM). (B) The linear relationship of ΔA and ATP concentrations. (C) UV–vis curves of the aptasensor for ATP, ADP, AMP, GTP, and CTP detection. Inset: The corresponding solution color of the aptasensor for different molecules detection. (D) The ΔA of the aptasensor for ATP, ADP, AMP, GTP, and CTP detection.
Figure 5. (A) UV–vis absorption spectra and photos of the CRISPR-enhanced colorimetric aptasensor in the presence of ATP at increasing concentrations (0.5, 1, 2, 3, 4, and 5 μM). (B) The linear relationship of ΔA and ATP concentrations. (C) UV–vis curves of the aptasensor for ATP, ADP, AMP, GTP, and CTP detection. Inset: The corresponding solution color of the aptasensor for different molecules detection. (D) The ΔA of the aptasensor for ATP, ADP, AMP, GTP, and CTP detection.
Biosensors 15 00651 g005
Figure 6. (A) Reproducibility and (B) stability of the CRISPR-enhanced colorimetric aptasensor. (C) The performance of the aptasensor for different concentrations of ATP (1 μM, 2 μM, 3 μM) in 1% serum by using standard addition method. (D) Comparison of the aptasensor for different concentrations of ATP (1 μM, 2 μM, 3 μM) detection in buffer and in 1% serum.
Figure 6. (A) Reproducibility and (B) stability of the CRISPR-enhanced colorimetric aptasensor. (C) The performance of the aptasensor for different concentrations of ATP (1 μM, 2 μM, 3 μM) in 1% serum by using standard addition method. (D) Comparison of the aptasensor for different concentrations of ATP (1 μM, 2 μM, 3 μM) detection in buffer and in 1% serum.
Biosensors 15 00651 g006
Table 1. Comparison of the performances of different colorimetric sensors for the determination of ATP.
Table 1. Comparison of the performances of different colorimetric sensors for the determination of ATP.
SensorLinear Range (μM)Limit of Detection (μM)Ref.
Carbon dot-based sensor0.05–2 μM0.034 μM[40]
Chlorophosphonazo III-Mg2+ complex-based sensor0–30 μM1.55 μM[41]
Quercetin@ZIF-90-based sensor2–80 μM0.58 μM[42]
Zeolitic imidazolate framework-based sensor10–240 μM3.85 μM[43]
CRISPR-mediated sensor5–50 μM2.5 μM[24]
CRISPR-enhanced aptasensor0.5–5 μM0.14 μMThis work
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhu, Z.; Ma, H.; Yao, H.; Yuan, Y.; Miao, X.; Su, S. CRISPR-Enhanced Colorimetric Aptasensor for Adenosine Triphosphate Detection Based on MoS2-Based Nanozymes. Biosensors 2025, 15, 651. https://doi.org/10.3390/bios15100651

AMA Style

Zhu Z, Ma H, Yao H, Yuan Y, Miao X, Su S. CRISPR-Enhanced Colorimetric Aptasensor for Adenosine Triphosphate Detection Based on MoS2-Based Nanozymes. Biosensors. 2025; 15(10):651. https://doi.org/10.3390/bios15100651

Chicago/Turabian Style

Zhu, Zhiqiang, Haojie Ma, Huashan Yao, Yuan Yuan, Xiangyang Miao, and Shao Su. 2025. "CRISPR-Enhanced Colorimetric Aptasensor for Adenosine Triphosphate Detection Based on MoS2-Based Nanozymes" Biosensors 15, no. 10: 651. https://doi.org/10.3390/bios15100651

APA Style

Zhu, Z., Ma, H., Yao, H., Yuan, Y., Miao, X., & Su, S. (2025). CRISPR-Enhanced Colorimetric Aptasensor for Adenosine Triphosphate Detection Based on MoS2-Based Nanozymes. Biosensors, 15(10), 651. https://doi.org/10.3390/bios15100651

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop